中国药业
中國藥業
중국약업
China Pharmaceuticals
2015年
18期
119-120
,共2页
慢性牙髓炎%氢氧化钙%樟脑酚%根管治疗%临床疗效%安全性
慢性牙髓炎%氫氧化鈣%樟腦酚%根管治療%臨床療效%安全性
만성아수염%경양화개%장뇌분%근관치료%림상료효%안전성
chronic pulpitis%calcium hydroxide%camphor phenol%root canal therapy%clinical efficacy%safety
目的：对比樟脑酚与氢氧化钙治疗慢性牙髓炎的疗效及安全性。方法选取慢性牙髓炎行根管治疗患者118例，患牙146颗，按随机数字表法分为对照组59例、患牙74颗和观察组59例、患牙72颗。两组患者均预备根管，对照组患者采用樟脑酚填充，观察组患者采用氢氧化钙填充。随访1个月。结果两组患者治疗后患牙疼痛及活动度评分均有明显降低，且观察组患者降低程度更明显（ P﹤0.05）；观察组患者疼痛缓解时间为（9.62±3.36）h，显著短于对照组的（18.39±4.53）h（ P﹤0.05）；观察组患者总有效率为84.72%，显著高于对照组的75.68%（ P﹤0.05）；对照组不良反应发生率显著高于观察组（ P﹤0.05）。结论氢氧化钙根管内封药治疗慢性牙髓炎，短期疗效确切，能快速缓解疼痛，改善患牙活动度，远期疗效更好，且不良反应较少，值得临床推广。
目的：對比樟腦酚與氫氧化鈣治療慢性牙髓炎的療效及安全性。方法選取慢性牙髓炎行根管治療患者118例，患牙146顆，按隨機數字錶法分為對照組59例、患牙74顆和觀察組59例、患牙72顆。兩組患者均預備根管，對照組患者採用樟腦酚填充，觀察組患者採用氫氧化鈣填充。隨訪1箇月。結果兩組患者治療後患牙疼痛及活動度評分均有明顯降低，且觀察組患者降低程度更明顯（ P﹤0.05）；觀察組患者疼痛緩解時間為（9.62±3.36）h，顯著短于對照組的（18.39±4.53）h（ P﹤0.05）；觀察組患者總有效率為84.72%，顯著高于對照組的75.68%（ P﹤0.05）；對照組不良反應髮生率顯著高于觀察組（ P﹤0.05）。結論氫氧化鈣根管內封藥治療慢性牙髓炎，短期療效確切，能快速緩解疼痛，改善患牙活動度，遠期療效更好，且不良反應較少，值得臨床推廣。
목적：대비장뇌분여경양화개치료만성아수염적료효급안전성。방법선취만성아수염행근관치료환자118례，환아146과，안수궤수자표법분위대조조59례、환아74과화관찰조59례、환아72과。량조환자균예비근관，대조조환자채용장뇌분전충，관찰조환자채용경양화개전충。수방1개월。결과량조환자치료후환아동통급활동도평분균유명현강저，차관찰조환자강저정도경명현（ P﹤0.05）；관찰조환자동통완해시간위（9.62±3.36）h，현저단우대조조적（18.39±4.53）h（ P﹤0.05）；관찰조환자총유효솔위84.72%，현저고우대조조적75.68%（ P﹤0.05）；대조조불량반응발생솔현저고우관찰조（ P﹤0.05）。결론경양화개근관내봉약치료만성아수염，단기료효학절，능쾌속완해동통，개선환아활동도，원기료효경호，차불량반응교소，치득림상추엄。
Objective To compare the efficacy and safety of camphor phenol ( CP ) and calcium hydroxide in treating chronic pulpi-tis. Methods 118 cases of chronic pulpitis patients,totally 146 teeth,were selected and randomly divided into the control group(59 cases, 74 teeth)and the observation group(59 cases,72 teeth). The two groups were given root canal preparation,the control group was treat-ed with CP filling,the observation group was treated with calcium hydroxide filling. The two groups were followed up for 1 month. Results The dental pain and teeth mobility degree of the two groups were significantly lower after treatment,and the observation group decreased more than the control group ( P ﹤ 0. 05);the pain relieving time of the observation group was (9. 62 ± 3. 36)h,which was significantly shorter than (18. 39 ± 4. 53) h of the control group ( P ﹤ 0. 05);the total effective rate of the observation group was 84. 72%,which was significantly higher than 75. 68% of the control group( P ﹤ 0. 05);the incidence rate of adverse reactions in the control groupwas significantly higher than the observed group( P ﹤ 0. 05). Conclusion The root calcium hydroxide intracanal medica-tion in treating chronic pulpitis has exact clinical efficacy in short term,can relieve pain instantly,improve the teeth mobility degree, and has a better long term efficacy with less adverse reactions,and is worth of clinical promotion.
